As a result, another patient with advanced pancreatic cancer not reported here was found to have an MLH1 gene mutation on our routine screening for MMR genes and treated with a PD1 inhibitor resulting in a partial response. The gene discussed is MLH1; the disease is pancreatic neoplasm.